First Time Loading...

Penumbra Inc
NYSE:PEN

Watchlist Manager
Penumbra Inc Logo
Penumbra Inc
NYSE:PEN
Watchlist
Price: 208.55 USD 1.21% Market Closed
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one PEN stock under the Base Case scenario is 122.69 USD. Compared to the current market price of 208.55 USD, Penumbra Inc is Overvalued by 41%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

PEN Relative Value
Base Case
122.69 USD
Overvaluation 41%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.6
P/S
P/S
Price to Sales
7.6
vs History
88
vs Industry
18
Median 3Y
11
Median 5Y
11.2
Industry
2.4
Forward
6.4
More Details
88.7
P/E
P/E
Price to Earnings
88.7
vs History
63
vs Industry
5
Median 3Y
107
Median 5Y
126.6
Industry
23.4
Forward
71.9
More Details
82.9
P/OCF
P/OCF
Price to OCF
82.9
vs History
53
vs Industry
3
Median 3Y
81.9
Median 5Y
100
Industry
15.5
More Details
100.7
P/FCFE
P/FCFE
Price to FCFE
100.7
vs History
30
vs Industry
5
Median 3Y
-161.2
Median 5Y
-128.7
Industry
23.2
More Details
6.8
P/B
P/B
Price to Book Value
6.8
vs History
88
vs Industry
11
Median 3Y
8.9
Median 5Y
11
Industry
2.3
More Details
7.4
EV/S
EV/S
Enterprise Value to Sales
7.4
vs History
90
vs Industry
17
Median 3Y
10.7
Median 5Y
10.9
Industry
2.5
Forward
6.2
More Details
11.4
EV/GP
EV/GP
Enterprise Value to Gross Profit
11.4
vs History
92
vs Industry
20
Median 3Y
17
Median 5Y
16.8
Industry
5.3
More Details
65.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
65.5
vs History
73
vs Industry
3
Median 3Y
97.2
Median 5Y
126.4
Industry
12.6
Forward
43.5
More Details
85
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
85
vs History
68
vs Industry
3
Median 3Y
139.3
Median 5Y
139.3
Industry
17.2
Forward
55.7
More Details
80.2
EV/OCF
EV/OCF
Enterprise Value to OCF
80.2
vs History
53
vs Industry
3
Median 3Y
79.2
Median 5Y
97.2
Industry
15.3
More Details
95
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
95
vs History
34
vs Industry
4
Median 3Y
-129.2
Median 5Y
-128.6
Industry
19.8
More Details
6.3
EV/IC
EV/IC
Enterprise Value to IC
6.3
vs History
85
vs Industry
14
Median 3Y
8.3
Median 5Y
11.1
Industry
2
More Details

Multiples Across Competitors

PEN Competitors Multiples
Penumbra Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Penumbra Inc
NYSE:PEN
8.1B USD 7.6 88.7 65.5 85
US
Abbott Laboratories
NYSE:ABT
183.6B USD 4.6 32.6 19.2 28.6
US
Intuitive Surgical Inc
NASDAQ:ISRG
135.3B USD 18.5 68.1 55.8 70
US
Stryker Corp
NYSE:SYK
125.1B USD 6 37.2 24.2 29.7
IE
Medtronic PLC
NYSE:MDT
108.6B USD 3.4 25.9 13.8 19.5
US
Boston Scientific Corp
NYSE:BSX
106.8B USD 7.3 60.5 30.8 45.5
US
Becton Dickinson and Co
NYSE:BDX
67.8B USD 3.5 55.6 18.6 39.4
DE
Siemens Healthineers AG
XETRA:SHL
57.9B EUR 2.7 38.1 18.3 30.9
US
Edwards Lifesciences Corp
NYSE:EW
51.3B USD 8.4 36.3 26.4 28.5
US
Dexcom Inc
NASDAQ:DXCM
50.8B USD 13.4 79.5 59.5 77.4
CN
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
368.4B CNY 10.7 32.5 28.3 28.3

See Also

Summary
PEN intrinsic value, competitors valuation, and company profile.
DCF Valuation
PEN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
PEN stock valuation using valuation multiples.
Wall Street Estimates
PEN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
PEN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.